Renhe Pharmacy Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	1,094	2,774	2,329	2,615	2,825	2,360
Short-Term Investments	264.25	139.21	385.49	155.37	290.03	100
Trading Asset Securities	2,778	1,093	1,017	764.59	416.87	315.6
Cash & Short-Term Investments	4,136	4,006	3,731	3,534	3,532	2,776
Cash Growth	1.81%	7.37%	5.57%	0.06%	27.25%	-3.83%
Accounts Receivable	520.22	271.67	466.59	500.18	477.59	539.8
Other Receivables	12.16	8.92	6.03	8.26	8.82	10.02
Receivables	532.38	280.59	472.62	508.44	486.41	549.82
Inventory	283.62	531.11	486.94	446.58	457.74	601.35
Other Current Assets	83.86	126.4	129.04	94.2	104.33	128.46
Total Current Assets	5,036	4,944	4,820	4,584	4,581	4,056
Property, Plant & Equipment	1,270	1,339	1,423	1,250	1,241	1,112
Long-Term Investments	623.4	602.55	330.91	30.48	536.41	392.69
Goodwill	390.89	390.89	501.91	546.91	578.24	606.12
Other Intangible Assets	285.32	293.96	313.44	420.72	582.87	342.74
Long-Term Deferred Tax Assets	27.59	32.3	32.65	28.25	20.85	6.64
Long-Term Deferred Charges	16.15	14.29	14.59	16.34	22.93	310.64
Other Long-Term Assets	121.25	117.89	46.63	568.04	71.9	81.83
Total Assets	7,770	7,735	7,482	7,445	7,635	6,908

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Accounts Payable	142.02	170.79	132.08	123.5	199.62	176.08
Accrued Expenses	33.66	55.23	46.44	33.49	103.52	110.71
Current Portion of Leases	1.3	0.89	0.69	5.79	6.72	2.84
Current Income Taxes Payable	115.36	94.24	72.54	209.63	224.76	211.59
Current Unearned Revenue	100.89	165.47	107.67	124.94	354.56	200.61
Other Current Liabilities	261.35	276.14	276.93	253.67	275.33	266.84
Total Current Liabilities	654.58	762.76	636.35	751.01	1,165	968.66
Long-Term Leases	0.92	1.33	1.89	-	5.79	3.62
Long-Term Unearned Revenue	35.11	38.93	37.96	37.11	38.83	8.25
Long-Term Deferred Tax Liabilities	0.21	0.07	0.11	1.88	3.66	0.28
Other Long-Term Liabilities	0.18	0.18	0.18	0.18	0.18	0.18
Total Liabilities	691	803.26	676.48	790.18	1,213	981

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Common Stock	1,400	1,400	1,400	1,400	1,400	1,400
Additional Paid-In Capital	752.76	752.76	796.39	810.81	785.76	766.66
Retained Earnings	4,390	4,228	4,044	3,842	3,555	3,121
Treasury Stock	-162.28	-64.64	-66.96	-60.08	-	-
Comprehensive Income & Other	-0.05	-0.01	-	-	-	-
Total Common Equity	6,380	6,316	6,174	5,993	5,741	5,287
Minority Interest	699.25	616.28	632.32	661.46	681	639.65
Shareholders' Equity	7,079	6,932	6,806	6,655	6,422	5,927
Total Liabilities & Equity	7,770	7,735	7,482	7,445	7,635	6,908

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Total Debt	2.22	2.22	2.58	5.79	12.52	6.46
Net Cash (Debt)	4,134	4,004	3,729	3,529	3,520	2,770
Net Cash Growth	1.80%	7.39%	5.67%	0.25%	27.09%	-1.86%
Net Cash Per Share	2.94	2.85	2.67	2.52	2.51	2.00
Filing Date Shares Outstanding	1,382	1,417	1,307	1,384	1,400	1,400
Total Common Shares Outstanding	1,382	1,417	1,307	1,391	1,400	1,400
Working Capital	4,381	4,182	4,183	3,833	3,416	3,087
Book Value Per Share	4.62	4.46	4.72	4.31	4.10	3.78
Tangible Book Value	5,704	5,631	5,358	5,025	4,580	4,338
Tangible Book Value Per Share	4.13	3.97	4.10	3.61	3.27	3.10
Buildings	-	1,675	1,516	1,163	1,001	665.33
Machinery	-	575.14	548.17	539.32	549.98	513.22
Construction In Progress	-	53.52	230.72	345.43	409.27	580.58